Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective treatments for type 2 diabetes (T2D). Here, we describe the in vitro characteristics and anti-diabetic in vivo efficacy of the novel GLP-1RA GL0034.

In vivo and in vitro characterisation of GL0034, a novel long-acting GLP-1 receptor agonist

Piemonti, Lorenzo;
2022

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective treatments for type 2 diabetes (T2D). Here, we describe the in vitro characteristics and anti-diabetic in vivo efficacy of the novel GLP-1RA GL0034.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/130115
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact